NCT04976829

Brief Summary

Antibiotic resistance is one of the most pressing health threats that mankind faces now and in the coming decades. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality. In order to tackle antibiotic resistance, a computerized-decision support system (CDSS) facilitating antibiotic stewardship and an electronic surveillance software (ESS) facilitating infection prevention and control activities will implement in our tertiary care university hospital. The investigators conduct a pragmatic, prospective, single-centre, before-after uncontrolled study with an interrupted time-series analysis 12 months before and 12 months after the introduction of the CDSS for antibiotic stewardship (APSS) and ESS for infection surveillance (ZINC). APSS and ZINC will assist respectively the antibiotic stewardship and the infection prevention and control teams of Nancy University Hospital (France). The investigators will evaluate the impact of the CDSS/ESS on the antibiotic use in adult (≥ 18 years) inpatients (hospitalised ≥ 48h). The primary outcome is the prescription rate by all healthcare professionals from the hospital of all systemic antibiotics expressed in defined daily doses/1 000 patients/month. Concurrently, the investigators will assess the safety of the intervention, its impact on the appropriateness of antibiotic prescriptions and on additional precautions (isolation precautions) as recommended in guidelines, and on bacterial epidemiology (multidrug-resistant bacteria and Clostridioides difficile infections) in the hospital. Finally, the investigators will evaluate the users' satisfaction and the cost of this intervention from the hospital perspective.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 26, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

August 26, 2021

Status Verified

July 1, 2021

Enrollment Period

1 year

First QC Date

July 15, 2021

Last Update Submit

August 20, 2021

Conditions

Keywords

Antibiotic stewardshipHealthcare associated infectionClinical decision supportInterrupted time seriesInfection prevention and controlAntibiotic resistance

Outcome Measures

Primary Outcomes (1)

  • Prescription rate of all systemic antibiotics

    The prescription rate by all healthcare professionals from the Nancy University Hospital of all systemic antibiotics (J01 code according to the Anatomical Therapeutic Chemical - ATC - 2017 classification) expressed in DDDs/1 000 patients/month.

    Calculated monthly during a 12-month before and 12-month after period

Secondary Outcomes (10)

  • All-cause intra-hospital mortality rate

    Calculated monthly during a 12-month before and 12-month after period

  • Average length of stay

    Calculated monthly during a 12-month before and 12-month after period

  • Incidence of healthcare associated infections

    Calculated monthly during a 12-month before and 12-month after period

  • Use of overall antibiotics and by therapeutic classes

    Calculated monthly during a 12-month before and 12-month after period

  • Proportion of the antibiotic prescriptions compliant with guidelines

    Calculated monthly during a 12-month before and 12-month after period

  • +5 more secondary outcomes

Study Arms (1)

adult (≥ 18 years) inpatients (hospitalised ≥ 48h)

Device: Antibiotic stewardship and healthcare-associated infections surveillance assisted by computer

Interventions

Implementation - in our tertiary care university hospital - of a computerized-decision support system (CDSS) facilitating antibiotic stewardship and of an electronic surveillance software (ESS) facilitating infection prevention and control activities

adult (≥ 18 years) inpatients (hospitalised ≥ 48h)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Nancy University Hospital (France) is a 1 497-bed tertiary-care hospital including two main geographical sites. In 2017, the point prevalence on one single day of patients treated with antibiotics was 24.4% and the prevalence of HCAI was 7.8% in this University Hospital. And the total antibiotic consumption was 591 DDD/1 000 hospital days. The study includes the inpatients of hospital departments of medicine (intensive care, cardiology, hepato-gastro-enterology, haematology, pneumology, infectious diseases, neurology, …), surgery, long-term care, and rehabilitation care. All inpatients ≥ 18 years and hospitalised ≥ 48h in Nancy University Hospital will be considered in the study.

You may qualify if:

  • All inpatients ≥ 18 years and hospitalised ≥ 48h in Nancy University Hospital

You may not qualify if:

  • The paediatric and gynaeco-obstetric departments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Baudet A, Agrinier N, Charmillon A, Pulcini C, Lozniewski A, Aissa N, Lizon J, Thilly N, Demore B, Florentin A. Evaluating antibiotic stewardship and healthcare-associated infections surveillance assisted by computer: protocol for an interrupted time series study. BMJ Open. 2022 Apr 5;12(4):e056125. doi: 10.1136/bmjopen-2021-056125.

MeSH Terms

Conditions

Cross Infection

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Arnaud Florentin, Dr

    Université de Lorraine, CHRU-Nancy, APEMAC EA4360, F-54000 Nancy, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arnaud Florentin, Dr

CONTACT

Alexandre Baudet, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2021

First Posted

July 26, 2021

Study Start

September 1, 2021

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

August 26, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share